Metabolic Medicine · Ochronosis

Building Your Care Team

At a Glance

People with ochronosis often need coordinated care: a metabolic specialist may lead alkaptonuria treatment, while dietitians, genetic counselors, eye, joint, heart, and skin specialists support monitoring. Bring product, imaging, pathology, and laboratory records.

Because ochronosis is rare, many clinicians have limited experience with it. Building a coordinated care team and acting as an advocate for your own medical records is often the most effective way to manage the disease ^[1]. You can ask your doctor if they are willing to consult with a metabolic or rare-disease center for guidance.

The Core Medical Team

The specialists you need depend entirely on your specific diagnosis. For exogenous ochronosis (EO), a patient mainly needs a dermatologist and routine primary care ^[2]. For alkaptonuria (AKU), care is specialized and tailored to your specific symptoms and treatment ^[1].

Metabolic Specialist: An inherited-metabolic-disease specialist can act as the lead of the AKU team. They are often the ones who prescribe nitisinone and monitor your overall chemical balance ^[1]^[3].
Metabolic Registered Dietitian (RD): A dietitian is a non-negotiable core member of your team if you are taking nitisinone. They ensure you are getting enough calories and essential amino acids while on a protein-restricted diet, preventing malnutrition and loss of muscle mass ^[4]^[5].
Genetic Counselor: For AKU, a genetic counselor helps interpret HGD testing, explains carrier status, and assists with family risk interpretation and reproductive planning. Relatives should not pursue broad testing without counseling.
Ophthalmologist: If you are taking nitisinone, you need an eye doctor who can perform a slit-lamp examination to look for tiny, asymptomatic crystals ^[6]^[7].
Rheumatologist or Orthopedic Surgeon: Referrals are made based on your specific joint symptoms to manage arthritis pain or perform joint replacements if damage becomes severe ^[8]^[1].
Cardiologist: Depending on your age and symptoms, a cardiologist will perform periodic echocardiograms to monitor for aortic stenosis ^[9]^[10].
Dermatologist: For those with exogenous ochronosis, a dermatologist is the primary provider to evaluate the pigment and manage treatments ^[2]^[11].

Preparing for Your First Consultation

When you see a specialist for the first time, you are your own best advocate. Bringing the right “evidence” can significantly speed up your diagnosis and treatment plan.

Product History (for EO): If you suspect your skin changes are from a cream, bring the exact products (or photos of the ingredient labels) you have used. Look specifically for hydroquinone, phenol, or resorcinol ^[2].
Imaging and Pathology: Don’t just bring the “summary” report. Bring the actual discs of your MRIs or X-rays. If you had a skin biopsy, bring the pathology report ^[12]^[13].
Laboratory History: Any previous urine tests that mention “darkening” or “homogentisic acid” are vital to establish the timeline of your disease ^[14].

Coordinated Care and Support

In rare diseases, doctors sometimes work in “silos,” meaning the heart doctor might not talk to the metabolic doctor. It is helpful to ask your lead specialist to coordinate. Ensure that every specialist you see sends a copy of their office notes to your metabolic doctor ^[1].

Visible skin discoloration, chronic pain, delayed diagnosis, and uncertainty can affect mood, work, relationships, and willingness to socialize. Discuss pain or appearance-related distress with your care team. They can provide concrete suggestions for counseling, occupational therapy, and rare-disease patient advocacy groups that offer peer support and help navigating the healthcare system.

Common questions in this guide

Who should be on an alkaptonuria care team?

A metabolic specialist often coordinates alkaptonuria care. Depending on symptoms and treatment, the team may include a metabolic dietitian, genetic counselor, ophthalmologist, rheumatologist or orthopedic surgeon, cardiologist, and primary care clinician.

Why is a dietitian important when taking nitisinone for AKU?

Nitisinone treatment may be paired with a protein-restricted diet, so a metabolic dietitian helps you get enough calories and essential amino acids. This support is intended to reduce the risk of malnutrition and loss of muscle mass.

What records should I take to an ochronosis specialist appointment?

Bring the actual MRI or X-ray images, not only the written report, along with any skin-biopsy pathology report and prior laboratory or urine results. If you may have exogenous ochronosis, bring the skin products or clear photos of their ingredient labels, especially products containing hydroquinone, phenol, or resorcinol.

What eye checks are needed during nitisinone treatment?

An ophthalmologist can perform a slit-lamp examination to look for small eye crystals that may not cause symptoms. Ask your treating team how often these examinations are needed as part of your nitisinone monitoring.

How can my doctors coordinate care for ochronosis?

Ask a lead specialist or your primary care clinician to help connect the metabolic, heart, eye, joint, and skin teams. Request that each specialist sends visit notes and test results to the clinician coordinating your care.

Can ochronosis affect emotional well-being?

Visible skin changes, chronic pain, delayed diagnosis, and uncertainty can affect mood, work, relationships, and social activities. Tell your care team if this happens; counseling, occupational therapy, and rare-disease peer support may help.

Get notified when new evidence is published on ochronosis disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (14)

1
Alkaptonuria.
Bernardini G, Braconi D, Zatkova A, et al.
Nature reviews. Disease primers 2024; (10(1)):16 doi:10.1038/s41572-024-00498-x.
PMID: 38453957
2
Exogenous Ochronosis (EO): Skin lightening cream causing rare caviar-like lesion with banana-like pigments; review of literature and histological comparison with endogenous counterpart.
Qorbani A, Mubasher A, Sarantopoulos GP, et al.
Autopsy & case reports 2020; (10(4)):e2020197 doi:10.4322/acr.2020.197.
PMID: 33344320
3
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial.
Ranganath LR, Psarelli EE, Arnoux JB, et al.
The lancet. Diabetes & endocrinology 2020; (8(9)):762-772 doi:10.1016/S2213-8587(20)30228-X.
PMID: 32822600
4
Dietary restriction of tyrosine and phenylalanine lowers tyrosinemia associated with nitisinone therapy of alkaptonuria.
Hughes JH, Wilson PJM, Sutherland H, et al.
Journal of inherited metabolic disease 2020; (43(2)):259-268 doi:10.1002/jimd.12172.
PMID: 31503358
5
Efficacy of Phenylalanine- and Tyrosine-Restricted Diet in Alkaptonuria Patients on Nitisinone Treatment: Case Series and Review of Literature.
Teke Kisa P, Eroglu Erkmen S, Bahceci H, et al.
Annals of nutrition & metabolism 2022; (78(1)):48-60 doi:10.1159/000519813.
PMID: 34736252
6
Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria.
Khedr M, Judd S, Briggs MC, et al.
JIMD reports 2018; (40()):31-37 doi:10.1007/8904_2017_62.
PMID: 28942493
7
Comparing the Phenylalanine/Tyrosine Pathway and Related Factors between Keratopathy and No-Keratopathy Groups as Well as between Genders in Alkaptonuria during Nitisinone Treatment.
Ranganath LR, Milan AM, Hughes AT, et al.
Metabolites 2022; (12(8)) doi:10.3390/metabo12080772.
PMID: 36005644
8
Clinical and radiological outcomes of total joint arthroplasty in patients with ochronotic arthropathy.
Rajkumar N, Soundarrajan D, Dhanasekararaja P, Rajasekaran S
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie 2020; (30(5)):923-929 doi:10.1007/s00590-020-02651-0.
PMID: 32172376
9
Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: Analysis of a large cohort of eighty-one alkaptonuria patients.
Ranganath LR, Heseltine T, Khedr M, Fisher MF
Molecular genetics and metabolism 2021; (133(3)):324-331 doi:10.1016/j.ymgme.2021.05.007.
PMID: 34059444
10
Effect of Nitisinone on Aortic Stenosis Disease Progression in Patients With Alkaptonuria: An Analysis of the Suitability of Nitisinone in Alkaptonuria (SONIA) 2 Study.
Bruce C, Meenamkuzhy-Hariharan P, Hussain S, et al.
Cureus 2025; (17(12)):e100123 doi:10.7759/cureus.100123.
PMID: 41589138
11
Clinical and Dermoscopic Characteristics of Facial Hyperpigmentation Disorders in Skin of Color.
Mansilla-Polo M, Díaz-Gómez CJ, Morgado-Carrasco D
Actas dermo-sifiliograficas 2026; (117(7)):104637 doi:10.1016/j.ad.2026.104637.
PMID: 41865981
12
[Exogenous ochronosis: An underdiagnosed cause of acquired facial hyperpigmentation].
Pelloux M, Lesport C, Guinet É, Gil H
Annales de pathologie 2026; doi:10.1016/j.annpat.2026.08.001.
PMID: 42648955
13
Management of a pseudarthrosis with sagittal malalignment in a patient with ochronotic spondyloarthropathy.
Alkasem W, Boissiere L, Obeid I, Bourghli A
European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society 2019; (28(10)):2283-2289 doi:10.1007/s00586-019-06020-2.
PMID: 31175484
14
Alkaptonuria in Turkey: Clinical and molecular characteristics of 66 patients.
Kisa PT, Gunduz M, Dorum S, et al.
European journal of medical genetics 2021; (64(5)):104197 doi:10.1016/j.ejmg.2021.104197.
PMID: 33746036

This page is for informational purposes only and does not constitute medical advice. Your metabolic specialist and other clinicians should tailor your ochronosis care plan, including nitisinone monitoring and dietary needs.